Tuesday, February 10, 2026

3:00PM – 4:00PM ET

Please note this virtual program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.

 FACULTY

Judy E. Kim, MD, FARVO, FASRS Jean and Tom Walter Distinguished Chair in Ophthalmology, in Honor of James P. McCulley, MD Professor of Ophthalmology, Vitreoretinal Diseases and Surgery Vice-Chair of Education Medical Director of Clinical Research University of Texas Southwestern Medical Center Dallas, Texas

PROGRAM OVERVIEW

This virtually live Clinical Conversation will overview current barriers in the treatment of DR and DME, focusing on the role that second-generation anti-VEGF agents have in addressing these barriers and improving outcomes. The rationale, efficacy, and safety of second-generation anti-VEGF agents will be covered, and case-based discussions will go into detail on how to apply these agents to patient care, including dosing strategies, appropriate patient selection, and treatment optimization.

TARGET AUDIENCE

This initiative is designed to meet the educational needs of retina specialists and comprehensive ophthalmologists involved in the management of patients with retinal disease.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Evaluate the latest evidence with second-generation anti-VEGF agents for DR and DME, as well as how their efficacy, safety, and durability address current barriers to care and reduces treatment burden
• Design individualized treatment strategies that incorporate patient factors and current real-world and clinical trial data on efficacy and safety of second-generation agents to minimize treatment burden and optimize visual outcomes for patients with DR and DME

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based.

This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]